Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

References

• Glossary. Accessed May, 2020. https://ichgcp.net/1-glossary/
   Google Scholar
• Dimasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33. doi:10.1016/j.jhealeco.2016.01.012.
   PubMed Web of Science ®Google Scholar
• Epstein M. Clinical trials in the developing world. Lancet. 2007;369:1859. doi:10.1016/S0140-6736(07)60846-0.
   PubMed Web of Science ®Google Scholar
• Buekens P, Keusch G, Belizan J, Bhutta ZA. Evidence-based global health. JAMA. 2004;291:2639–41. doi:10.1001/jama.291.21.2639.
   PubMed Web of Science ®Google Scholar
• Siegfried N, Merwe VDL, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011 Jul;6(7):CD003510.
   Google Scholar
• Soares WK, Maclehose H, Bergman H, Goldberg E, Pitan F, Cunliffe N. Vac-cines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;11:CD008521.
   PubMed Web of Science ®Google Scholar
• Røttingen JA, Chamas C, Goyal L, Harb H, Lagrada L, Mayosi BM. Securing the public good of health research and development for developing countries. Bull World Health Organ. 2012;90:398–400. doi:10.2471/BLT.12.105460.
   PubMed Web of Science ®Google Scholar
• Moon S, Bermudez J, Hoen E. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Med. 2012;9:e1001218. doi:10.1371/journal.pmed.1001218.
   PubMed Web of Science ®Google Scholar
• Govindarajan R, Young JW, Harless CL, Hutchins LF. Barriers to clinical trials vary according to the type of trial and the institution. J Clin Oncol: J Am Soc Clin Oncol. 2007;25:1633–34. doi:10.1200/JCO.2006.09.6404.
   PubMed Web of Science ®Google Scholar
• Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, Schulman KM. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360:816–23. doi:10.1056/NEJMsb0803929.
   PubMed Web of Science ®Google Scholar
• Angell M. The ethics of clinical research in the third world. N Engl J Med. 1997;337:847–48. doi:10.1056/NEJM199709183371209.
   PubMed Web of Science ®Google Scholar
• Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med. 2001;345:139–42. doi:10.1056/NEJM200107123450212.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004;189:930–37. doi:10.1086/381709.
   PubMed Web of Science ®Google Scholar
• Rahman S, Majumder M, Shaban SF, Rahman N, Ahmed M, Abdulrahman KB, D’ Souza UJ. Physician participation in clinical research and trials: issues and approaches. Adv Med Educ Pract. 2011;2:85–93. doi:10.2147/AMEP.S14103.
   PubMedGoogle Scholar
• Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, Kim YE, Park JK, Wierzba TF. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk factor adjustment. Lancet Glob Health. 2014;2:e570–80. doi:10.1016/S2214-109X(14)70301-8.
   PubMed Web of Science ®Google Scholar
• Antillon M, Warren JL, Crawford FW, Weinberger DME, Kürüm E, Pak GD, Marks F, Pitzer ,VE. The burden of typhoid fever in low and middle-income countries: a meta-regression approach. PLoS Negl Trop Dis. 2017;11:e0005376. doi:10.1371/journal.pntd.0005376.
   PubMed Web of Science ®Google Scholar
• Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, Dopfer D, Fazil A, Fischer-Walkar CL, Hald T, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12:e1001921. doi:10.1371/journal.pmed.1001921.
   PubMed Web of Science ®Google Scholar
• Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, Bhutta ZA, Canh DG, Ali M, Shin S, et al. Domi typhoid study group. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86:260–68. doi:10.2471/BLT.06.039818.
   PubMed Web of Science ®Google Scholar
• John J, Van Aart CJ, Grassly NC, Baker S. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616. doi:10.1371/journal.pntd.0004616.
   PubMed Web of Science ®Google Scholar
• Syed KA, Saluja T, Cho H, Hsiao A, Shaikh H, Wartel TA, Mogasale V, Lynch J, Kim JH, Excler JL, et al. Review on the recent advances on typhoid vaccine development and challenges ahead. Clin Infect Dis®. 2020;71(S2):S141–50. doi:10.1093/cid/ciaa504.
   PubMed Web of Science ®Google Scholar
• Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital. J Nepal Health Res Counc. 2012 Sep;10(22):214–17.
   PubMedGoogle Scholar
• Karkey A, Aryjal A, Basnyat B, Baker S. Kathmandu, Nepal: still an enteric fever capital of the world. J Infect Dev Ctries. 2008;2:461–65.
   PubMed Web of Science ®Google Scholar
• Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants. Accessed May, 2020. https://clinicaltrials.gov/ct2/show/NCT03933098
   Google Scholar
• Typhoid Fever. Accessed June, 2020. https://www.ivi.int/what-we-do/disease-areas/typhoid/
   Google Scholar
• Integrated addendum to ICH E6(R1): Guideline for good clinical practice E6(R2). Accessed Aug, 2020. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf
   Google Scholar
• Shakya M, Jones RC, Nyland KT, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, et al. Efficacy of typhoid conjugate vaccine in nepal: an interim analysis of a participant-and observer-blinded randomized phase III trial. N Engl J Med. 2019 Dec 5;381(23):2209–18. doi:10.1056/NEJMoa1905047.
   PubMed Web of Science ®Google Scholar
• Li R, Barnes M, Aldinger C, Bierer B. Global clinical trials: ethics, harmonization and commitments to transparency. Global Health. 2015;4:2.
   Google Scholar
• Global Forum for Health Research & World Health Organization. Global forum for health research: an overview. Geneva: Global Forum for Health Research. 2000 Accessed June, 2020. https://apps.who.int/iris/handle/10665/66474
   Google Scholar
• Alemayehu C, Mitchell G, Nikles J. Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health. 2018;17:37. doi:10.1186/s12939-018-0748-6.
   PubMed Web of Science ®Google Scholar